Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED50 of propofol combined with nalbuphine in painless gastroscopy
ChiCTR2100053204Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Nov 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of nalbuphine and propofol in pain (2 arms), sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoints: Median effective dose (ED50), Dosage of propofol and 1 more. Started Nov 2021; status: recruiting.
02
Drugs
nalbuphinepropofol
03
Conditions
pain
Beyond the preview
Go deeper on ChiCTR2100053204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100053204.